News

Digital health sector will take advantage of landmark new UK-Australia Free Trade Agreement

Digital health sector will take advantage of landmark new UK-Australia Free Trade Agreement
Partnerships and Growth
Member News

Two digital health companies, ORCHA and Cogniss, have announced a global partnership that will benefit from the new UK-Australian Free Trade Agreement (FTA) which has just passed through the UK House of Commons and is anticipated to come into effect in 2023. Under the new partnership, apps created through the Cogniss no-code platform will meet ORCHA Baseline Review standards in relation to data, security and accessibility. This will streamline the app development and evaluation process, and enable healthcare professionals to develop bespoke content that meets professional assurance standards but without the need for them to have advanced technical expertise.

ORCHA signs historic partnership with Cogniss to unlock next generation of digital health. Two digital health companies, ORCHA and Cogniss, have announced a global partnership that will benefit from the new UK-Australian Free Trade Agreement (FTA) which has just passed through the UK House of Commons and is anticipated to come into effect in 2023.

The FTA will drive increased trade, two-way investment, economic growth and job creation.  It’s the first international FTA the UK government has negotiated from scratch since leaving the EU.

ORCHA is the UK-based world leader in digital health evaluation and distribution. Australian-based Cogniss is a no-code digital health platform which enables innovators to create solutions without any need for coding or technical expertise.

Under the new partnership, apps created through the Cogniss no-code platform will meet ORCHA Baseline Review standards in relation to data, security and accessibility. This will streamline the app development and evaluation process, and enable healthcare professionals to develop bespoke content that meets professional assurance standards but without the need for them to have advanced technical expertise.

It will also help reduce regulatory and technical barriers and increase quality; issues that frequently hinder solutions from making their way into the NHS and Medicare, Australia’s universal health care scheme.

Speaking at an event held at Australian High Commission hosted by Senator Hon Don Farrell, Fiona Costello, SVP of Accreditations at ORCHA said:

“We are often approached by clinicians with solutions to the problems they are facing, but they lack the time, resources and expertise to build them, therefore relying on commercial products that are not always a perfect fit. Alongside Cogniss, we can now help them to understand the criteria to create high quality technologies and, through this partnership, support them to develop market-ready solutions.”

Dr Lloyd Humphreys, Cogniss’s newly appointed Managing Director, said:

“Having founded and created a digital health solution for addictions back in 2009, it took over two years and a million pounds of investment. Since then, nothing has changed in the way we design and create apps. Cogniss represents a complete paradigm shift for the sector and working with ORCHA further accelerates the ability to lower the barriers for clinical entrepreneurs to create great technology that solves the challenges they are facing.”

Cogniss is currently setting up global headquarters in Cambridge with support from the UK Department of International Trade, Investment NSW and Austrade.

Discover more about ORCHA:

The Organisation for the Review of Care and Health Apps (ORCHA) is the world’s leading, independent digital health evaluation and distribution organisation. It helps health and care organisations to deliver the right digital health apps, to the right people, at the right time. Its unique insight, assessment, and implementation services are improving the health of the population, the health of our health systems and the health of the health app ecosystem. ORCHA conducts reviews for government organisations across Europe, the Middle East, and Australasia. In the UK, ORCHA conducts reviews for NHS Digital and NHS providers in 70% of regions.

NEWS​

Related News

Transforming Antimicrobial Resistance: The Role of Digital Integration in AMR EDUCare

17 Apr 2024
As a leading organisation in the digital health space, ECHAlliance supports this project as a beneficiary, contributing to various project work packag...

Spain – Basque Health Ecosystem is ECHAlliance Ecosystem of the Month – April

17 Apr 2024
This month we are featuring our Spain - Basque Health Ecosystem as our Ecosystem of the Month.

The Miguel Delibes Cultural Center has been the epicenter of the Sectoral Meeting on Care and Innovation that commemorates the 10th Anniversary of the SIVI Cluster

16 Apr 2024
This conference, organized by the SIVI Cluster, was presented as a space for reflection, exchange and recognition of the advances and outstanding cont...

CRANE: pre-commercial procurement project. FundeSalud participate in the co-creation sessions of the CRANE Project in Copenhagen

16 Apr 2024
Three European companies are designing a prototype of a possible technological solution for patients with chronic diseases (Diabetes, Cardiovascular D...

The use of innovation to improve the social health and care sector

16 Apr 2024
On April 9th, the online presentation day of the AEI 2023 Project took place; conference organized by the Cluster of Innovative Solutions for Independ...

Open Market Consultation Published for AI-Based Solutions in Healthcare in Catalonia

16 Apr 2024
The Catalan healthcare system has announced an upcoming open market consultation aimed at sourcing AI-based solutions to prevent medication-related he...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *